Online Program Home
My Program

Sessions Were Renumbered as of May 19.

CC-W = McCormick Place Convention Center, West Building,   CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,   UC= Conference Chicago at University Center
* = applied session       ! = JSM meeting theme

Activity Details

251 * ! Mon, 8/1/2016, 2:00 PM - 3:50 PM CC-W194b
Bayesian Modeling and Applications — Contributed Papers
Biopharmaceutical Section , International Society for Bayesian Analysis (ISBA) , Section on Bayesian Statistical Science
Chair(s): John Han, Johnson & Johnson
2:05 PM A Phase 2a Bayesian Adaptive Dose-Ranging Trial Evaluating Hypertension Therapy Richann Liu, Pfizer
2:20 PM A Simple Bayesian Design to Identify Maximum Tolerated Dose Contour for Drug Combination Trials Liangcai Zhang, Rice University ; Ying Yuan, MD Anderson Cancer Center
2:35 PM Exploring Bayesian Go/No-Go Decision Criteria in Clinical Trials Rodney Croos-Dabrera, Astellas Pharma ; Misun Lee, Astellas Pharma
2:50 PM Use of Bayesian Methods in Dose-Escalation Studies Mani Lakshminarayanan, Pfizer
3:05 PM Precision Medicine: How Bayesian Empirical Subgroup Analysis Plays a Role Judy X. Li, FDA ; Wei-Chen Chen, FDA/CBER ; John Scott, FDA
3:20 PM Bayesian Statistical Models Assessing Disease Modification Drug Effects Using Doubly Randomized Delayed-Start and Matched Control Designs Ibrahim Turkoz, Janssen R&D ; Marc Sobel, Temple University
3:35 PM Bayesian Modeling of Phase II Dose-Ranging Clinical Trials Shu-Yen Ho, PAREXEL
Copyright © American Statistical Association